VICL (Vical Labs) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Greg Jung who wrote (1222)	3/4/2000 5:13:00 PM
From: William Strop	Read Replies (2) of 1972

Greg, I agree with your view. The FDA has to be concerned after the PA. death, step up monitoring, etc..., otherwise they aren't doing their job. Regarding that subject, the WSJ (Friday, 3/3/2000) has an article re: the Vascular Genetics trials. Good reading for everyone with quotes from Vascular Genetics & Human Genome Sciences. Jeffrey Isner, chief researcher, was quoted as saying, "I am looking forward to the opportunity to present the results of these trials in two weeks, and at that time I believe the safety & efficacy will be more than apparent". I think he will be reporting sometime the week of 3/12/2000. Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next